978
Views
13
CrossRef citations to date
0
Altmetric
Author's View

Targeting programmed cell death ligand 1 in osteosarcoma: an auto-commentary on therapeutic potential

, , , &
Article: e954467 | Received 30 Jun 2014, Accepted 07 Jul 2014, Published online: 14 Nov 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Giulia Mesiano, Giovanni Grignani, Erika Fiorino, Valeria Leuci, Ramona Rotolo, Lorenzo D’Ambrosio, Chiara Salfi, Loretta Gammaitoni, Lidia Giraudo, Alberto Pisacane, Sara Butera, Ymera Pignochino, Marco Basiricó, Federica Capozzi, Anna Sapino, Massimo Aglietta & Dario Sangiolo. (2018) Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.. OncoImmunology 7:11.
Read now
François Bertucci, Pascal Finetti, Delphine Perrot, Agnès Leroux, Françoise Collin, Axel Le Cesne, Jean-Michel Coindre, Jean-Yves Blay, Daniel Birnbaum & Emilie Mamessier. (2017) PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas. OncoImmunology 6:3.
Read now
Cristina Meazza & Paolo Scanagatta. (2016) Metastatic osteosarcoma: a challenging multidisciplinary treatment. Expert Review of Anticancer Therapy 16:5, pages 543-556.
Read now
Claudia Maria Hattinger, Marilù Fanelli, Elisa Tavanti, Serena Vella, Stefano Ferrari, Piero Picci & Massimo Serra. (2015) Advances in emerging drugs for osteosarcoma. Expert Opinion on Emerging Drugs 20:3, pages 495-514.
Read now

Articles from other publishers (9)

Yang Wen, Fan Tang, Chongqi Tu, Francis Hornicek, Zhenfeng Duan & Li Min. (2022) Immune checkpoints in osteosarcoma: Recent advances and therapeutic potential. Cancer Letters 547, pages 215887.
Crossref
Christopher R. Cunningham, Leslie Dodd, Magda Esebua & Lester J. Layfield. (2021) PD-L1 expression in sarcomas: An immunohistochemical study and review of the literature. Annals of Diagnostic Pathology 55, pages 151823.
Crossref
Jun Zhang, Xubin Chou, Ming Zhuang, Chenlei Zhu, Yong Hu, Dong Cheng & Zhiwei Liu. (2020) Retracted : LINC00657 activates PD‐L1 to promote osteosarcoma metastasis via miR‐106a . Journal of Cellular Biochemistry 121:10, pages 4188-4195.
Crossref
Lu Xie, Jie Xu, Xin Sun, Xiaodong Tang, Kunkun Sun, Yuan Li & Wei Guo. (2020) Case reports with durable therapeutic effects from the prospective phase 2 trial. Medicine: Case Reports and Study Protocols 1:1, pages e0010.
Crossref
Diego Antonio Costa Arantes, Andr?ia Souza Gon?alves, Bruno Correia Jham, Eliza Carla Barroso Duarte, ?lbio Candido de Paula, Henrique Moura de Paula, Elismauro Francisco Mendon?a & Aline Carvalho Batista. (2017) Evaluation of HLA-G, HLA-E, and PD-L1 proteins in oral osteosarcomas. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 123:6, pages e188-e196.
Crossref
Marie-Françoise Heymann & Dominique Heymann. 2017. Osteosarcoma - Biology, Behavior and Mechanisms. Osteosarcoma - Biology, Behavior and Mechanisms.
Lynn Lee, Lin Fei, Jennifer Pope & Lars M. Wagner. (2017) Early Lymphocyte Recovery and Outcome in Osteosarcoma. Journal of Pediatric Hematology/Oncology 39:3, pages 179-183.
Crossref
C. Rory Goodwin, Nancy Abu-Bonsrah, Mark H. Bilsky, Jeremy J. Reynolds, Laurence D. Rhines, Ilya Laufer, Alexander C. Disch, Arpad Bozsodi, Shreyaskumar R. Patel, Ziya L. Gokaslan, Daniel M. Sciubba & Chetan Bettegowda. (2016) Clinical Decision Making. Spine 41:20, pages S171-S177.
Crossref
Vivek Subbiah, Michael J. Wagner, Mary F. McGuire, Nawid M. Sarwari, Eswaran Devarajan, Valerae O. Lewis, Shanon Westin, Shumei Kato, Robert E. Brown & Pete Anderson. (2015) Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine. Oncotarget 6:38, pages 40642-40654.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.